Skip to main content
. 1999 Sep;6(5):696–700. doi: 10.1128/cdli.6.5.696-700.1999

TABLE 1.

BDV seroprevalence among human patients by ECLIA with recombinant p40 and p24 proteins

Patient diagnosis Mean age + SD % Males/% females No. of positive sera/total no. (%)a
Schizophrenia 49.3 + 12.3 49/51 26/845 (3.08)
Mood disorders 55.6 + 14.0 39/61 9/251 (3.59)
Alcohol addiction 51.3 + 6.7 88/12 1/42 (2.38)
Mental retardation 38.6 + 13.4 60/40 0/25 (0)
Alzheimer’s disease 82.9 + 8.2 36/64 1/89 (1.12)
Vascular dementia 78.5 + 8.5 49/51 0/46 (0)
Other psychiatric diseases 57.0 + 17.2 48/52 0/164 (0)
 Subtotal 2/366 (0.55)
Neurological diseases 37.2 + 16.1 64/36 0/114 (0)
 Multiple sclerosis 0/67 (0)
 Encephalitis 0/33 (0)
 Degenerative diseases 0/14 (0)
Epilepsy 43.9 + 13.7 56/44 3/214 (1.40)
Chronic fatigue syndrome 32.0 + 9.8 60/40 0/75 (0)
HIV infection (including AIDS) 31.9 + 13.4 97/2 1/85 (1.18)
Autoimmune diseases 47.2 + 17.3 4/96 0/50 (0)
Leprosy 67.2 + 10.4 53/47 0/17 (0)
Multitransfused patients 50.6 + 18.6 52/48 3/66 (4.55)
Ocular diseases 50.1 + 19.1 42/58 19/1,393 (1.36)
Blood donors 35.1 + 13.1 69/31 10/917 (1.09)
a

Statistical analysis data are as follows: schizophrenia versus other psychiatric diseases (χ2 = 6.16; P, >0.01 and <0.025), schizophrenia versus blood donors (χ2 = 8.67; P < 0.005), schizophrenia versus ocular diseases (χ2 = 7.82; P, >0.01 and <0.01), mood disorders versus other psychiatric diseases (χ2 = 6.21; P, >0.025 and <0.01), mood disorders versus donors (χ2 = 7.67; P, >0.01 and <0.005), mood disorders versus ocular diseases (χ2 = 6.27; P, >0.025 and <0.01), and multitransfused patients versus donors (χ2 = 3.30; P, not significant).